Acasă › Cancer pulmonar cu celule non-pătrate › North Carolina › Durham
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Durham, NC
39 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Durham (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Duke University Medical Center, Durham
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
În curs de recrutareFaza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- Duke University, Durham
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
În curs de recrutareFaza 1
- Exelixis Clinical Site #12, Durham
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
În curs de recrutareFaza 3
- UNC Lineberger Comprehensive Cancer Center ( Site 3250), Chapel Hill · La 10 mi distanță
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
În curs de recrutareFaza 3
- Duke Cancer Center, Durham
A Study of PHN-012 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1
- PHN-012-001 Site, Durham
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
În curs de recrutareFaza 3
- UNC Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · La 10 mi distanță
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
În curs de recrutareFaza 3
- Duke University Medical Center, Durham
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 2
- University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
În curs de recrutareFaza 1/2
- Duke Cancer Center Durham, Durham
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
În curs de recrutareFaza 3
- Clinical Study Site, Durham
- Clinical Study Site, Chapel Hill · La 10 mi distanță
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
În curs de recrutareFaza 3
- Durham VA Health Care System, Durham
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
În curs de recrutareFaza 1/2
- Duke University School of Medicine, Durham
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
În curs de recrutareFaza 2/3
- Duke University Medical Center, Durham
Effects of Infusion Timing on Treatment Response in Solid Tumors
În curs de recrutareFaza 2
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · La 10 mi distanță
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
În curs de recrutareStudiu observațional
- UNC- Chapel Hill, Chapel Hill · La 10 mi distanță
A Phase 1/1b Study of IAM1363 in HER2 Cancers
În curs de recrutareFaza 1
- Duke Cancer Institute, Durham
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · La 10 mi distanță
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
În curs de recrutareFaza 1
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · La 10 mi distanță
- University of North Carolina, Chapel Hill · La 10 mi distanță
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
În curs de recrutareFaza 1/2
- Duke Cancer Institute, Durham
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
În curs de recrutareFaza 2
- UNC Health - University of North Carolina, Chapel Hill · La 10 mi distanță
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
În curs de recrutareFaza 1
- Duke University Medical Center, Durham
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
În curs de recrutareFaza 1/2
- Duke Cancer Institute, Durham
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- Duke Cancer Center, Durham
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
În curs de recrutareFaza 2
- University of North Carolina, Chapel Hill · La 10 mi distanță
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
În curs de recrutareFaza 1
- Duke Cancer Institute /ID# 276267, Durham
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- Research Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
În curs de recrutareFaza 1
- Research Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
În curs de recrutareFaza 1
- Duke Cancer Center /ID# 251975, Durham
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Durham VA Medical Center, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
În curs de recrutareFaza 1
- Duke Cancer Center, Durham
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Durham VA Medical Center, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
În curs de recrutare
- Durham VA Medical Center, Durham, NC, Durham
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
În curs de recrutareFaza 1 timpurie
- Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
GEMINI-NSCLC: NSCLC Biomarker Study
În curs de recrutareStudiu observațional
- Duke University, Durham
- UNC, Chapel Hill · La 10 mi distanță
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Chapel Hill · La 10 mi distanță
A Study of NX-1607 in Adults With Advanced Malignancies
În curs de recrutareFaza 1
- University of North Carolina, Chapel Hill · La 10 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Durham
- Cancer de sân64 studii
- Cancer (toate tipurile)58 studii
- Mielom multiplu37 studii
- Leucemie mieloasă acută33 studii
- Cancer metastatic33 studii
- Cancer de prostată32 studii
- Cancer pulmonar32 studii
- Cancer colorectal28 studii
- Cancer ovarian27 studii
- Leucemie limfatică cronică27 studii
- Insuficiență cardiacă26 studii
- Cancer pancreatic24 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.